Saturday 17 October 2026
Export CRKN’s income statement to Excel — free account
Crown Electrokinetics Corp.
CRKN Basic Materials Specialty Chemicals
Crown Electrokinetics Corp.’s revenue for fiscal 2024 (year ended December 2024) was $19.7 million, up 12,776.5% from fiscal 2023. In the quarter to March 2025, revenue grew 306.5%, EPS grew 99.8% and free cash flow fell 362.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
0.00
0.01
−100.00%
Follow CRKN
| Mar '25 | Dec '24 | Sep '24 | Jun '24 | Older periods | |
|---|---|---|---|---|---|
| (195.09%) | (241.21%) | (317.74%) | (416.46%) |
+8 more TTM periods Free account |
|
| (142.30%) | (145.89%) | (204.75%) | (197.36%) | ||
ROIC |
(134.95%) | (163.47%) | (186.21%) | (232.29%) | |
Return on Tangible Assets |
(108.10%) | (155.75%) | (390.70%) | (431.17%) | |
Average Days of Receivables |
82.75 | 99.23 | 132.02 | 223.97 | |
Free Cash Flow per Share |
(20.48) | (0.41) | (619.33) | (1,550.85) | |
Free Cash Flow |
(34.26) | (24.33) | (19.32) | (18.14) | |
Capital Expenditures |
(7.74) | (6.14) | (3.21) | (1.52) | |
| Other line items | |||||
Cash ROIC |
(58.12%) | (66.42%) | (145.07%) | (138.85%) | |
Accounts Receivable Turnover |
7.62 | 7.24 | 5.29 | 3.24 | |
Accounts Payable Turnover |
7.71 | 5.89 | 4.28 | 3.41 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
57.45 | 97.21 | 119.50 | 117.34 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
16.92% | 17.09% | 29.80% | 69.27% | |
Selling, General and Administrative Expense of Revenue |
118.97% | 101.75% | 125.46% | 243.95% | |
Share Based Compensation of Revenue |
32.54% | 26.65% | 35.99% | 51.73% | |
Interest Coverage |
473.77 | (24.27) | (6.17) | (3.21) | |
Operating CF/Net income |
0.71 | 0.56 | 0.53 | 0.60 | |
Depreciation/Fixed assets |
0.27 | 0.38 | 1.00 | 2.29 | |
Capex/Depreciation |
(3.04) | (1.92) | (0.60) | (0.22) | |
Revenue per Share |
13.03 | 0.33 | 431.44 | 466.75 | |
Operating CF per Share |
(15.85) | (0.31) | (516.38) | (1,420.77) | |
Capex per Share |
(4.63) | (0.10) | (102.95) | (130.09) | |
Capex to Sales |
0.36 | 0.31 | 0.24 | 0.28 |
Columns are period end dates